SANXING(SH:601567) Sou Hu Cai Jing·2025-08-20 10:42Group 1 - The core viewpoint of the articles highlights Samsung Medical's current stock performance, with a closing price of 25.19 yuan, an increase of 1.08%, and a rolling PE ratio of 14.84, marking a new low in 70 days, with a total market capitalization of 35.398 billion yuan [1][2] - The average PE ratio for the electric grid equipment industry is 39.42, with a median of 43.11, placing Samsung Medical at the 35th position within the industry [1] - As of March 31, 2025, Samsung Medical has 16,366 shareholders, a decrease of 898 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - For the first quarter of 2025, Samsung Medical reported an operating income of 3.631 billion yuan, a year-on-year increase of 20.03%, and a net profit of 489 million yuan, reflecting a year-on-year growth of 34.33%, with a sales gross margin of 28.90% [2] - The PE (TTM) for Samsung Medical is 14.84, while the static PE is 15.67, and the price-to-book ratio is 2.81, with a total market value of 35.398 billion yuan [2] - Comparatively, the industry average PE (TTM) is 39.42, with a static PE of 42.97 and a price-to-book ratio of 3.97, indicating that Samsung Medical's valuation is significantly lower than the industry average [2]